ML329

1 1

Selleck Chemicals

S0145-5MG

€144,00 EUR
€144,00 EUR
Sold out
Shipping calculated at checkout.
Supplier
Size
View full details

ML329 is an inhibitor linked to TGF-beta / Smad Signaling and related pathway-oriented research. It is especially relevant in developmental biology models, where defined compound exposure can be linked to Smad-mediated transcription, differentiation, and fibrotic signaling.

The pathway annotation connects ML329 to TGF-beta / Smad Signaling, supporting experiments that monitor Smad-mediated transcription, differentiation, and fibrotic signaling across biochemical, cellular, or phenotypic assay formats. This context is compatible with TGF-beta/Smad reporter and transcriptional assays, as well as transcriptional, biochemical, or phenotypic comparisons linked to the annotated pathway state. In developmental biology models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

  • Pathway perturbation studies connected to TGF-beta / Smad Signaling
  • Concentration-response inhibition and target-dependence studies
  • Phenotypic profiling in developmental biology models
  • Combination studies with orthogonal perturbagens

Overall, ML329 is well suited to pathway-oriented studies that need a defined compound input for TGF-beta / Smad Signaling readouts in developmental biology models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.

Pathways:
TGF-beta / Smad Signaling
Research Area:
Developmental Biology
CAS No.:
19992-50-8
Molecular Weight:
328.34
Formula:
C₁₆H₁₂N₂O₄S
SMILES:
C1=CC=C2C(=C1)C(=O)C=C(C2=O)NC3=CC=C(C=C3)S(=O)(=O)N
Storage Temperature:
-20°C

For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.

The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.